-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US31447E1055 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| PE Ratio | None |
|---|---|
| Target Price | 9 |
| Market Cap | 31M |
| Beta | -2.55 |
| Dividend Yield | None |
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-generating device for fallopian tube diagnosis. Its product candidate, FemBloc, is a non-surgical permanent birth control solution. It offers its products to reproductive endocrinologists for infertility products, gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for FEMY using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025